Neoadjuvant docetaxel combined with cisplatin and followed by radical surgery for the treatment of locally advanced (stage IB2 – IIB) cervical cancer: preliminary results of a single-institution experience

Bibliography

• Horn LC, Fischer U, Raptis G, Tumor size is of prognostic value in surgically treated FIGO stage II cervical cancer. Gynecol Oncol 2007;107:310-15
   PubMed Web of Science ®Google Scholar
• Trattner M, Graf AH, Lax S, Prognostic factors in surgically treated stage ib-iib cervical carcinomas with special emphasis on the importance of tumor volume. Gynecol Oncol 2001;82:11-16
   PubMed Web of Science ®Google Scholar
• Sundfor K, Trope CG, Hogberg T, Radiotherapy and neoadjuvant chemotherapy for cervical carcinoma. A randomized multicenter study of sequential cisplatin and 5-fluorouracil and radiotherapy in advanced cervical carcinoma stage 3B and 4A. Cancer 1996;77:2371-8
   PubMedGoogle Scholar
• Tattersall MH, Lorvidhaya V, Vootiprux V, ; Cervical Cancer Study Group of the Asian Oceanian Clinical Oncology Association. Randomized trial of epirubicin and cisplatin chemotherapy followed by pelvic radiation in locally advanced cervical cancer. J Clin Oncol 1995;13:444-51
   PubMed Web of Science ®Google Scholar
• Kumar L, Kaushal R, Nandy M, Chemotherapy followed by radiotherapy versus radiotherapy alone in locally advanced cervical cancer: a randomized study. Gynecol Oncol 1994;54:307-15
   PubMedGoogle Scholar
• Chiara S, Bruzzone M, Merlini L, Randomized study comparing chemotherapy plus radiotherapy versus radiotherapy alone in FIGO stage IIB – III cervical carcinoma. GONO (North-West Oncologic Cooperative Group). Am J Clin Oncol 1994;17:294-7
   PubMedGoogle Scholar
• Souhami L, Gil RA, Allan SE, A randomized trial of chemotherapy followed by pelvic radiation therapy in stage IIIB carcinoma of the cervix. J Clin Oncol 1991;9:970-7
   PubMed Web of Science ®Google Scholar
• Neoadjuvant Chemotherapy for Locally Advanced Cervical Cancer Meta-analysis Collaboration. Neoadjuvant chemotherapy for locally advanced cervical cancer: a systematic review and meta-analysis of individual patient data from 21 randomised trials. Eur J Cancer 2003;39:2470-86
   PubMed Web of Science ®Google Scholar
• Sardi JE, Giaroli A, Sananes C, Long-term follow-up of the first randomized trial using neoadjuvant chemotherapy in stage Ib squamous carcinoma of the cervix: the final results. Gynecol Oncol 1997;67:61-9
   PubMed Web of Science ®Google Scholar
• Benedetti-Panici P, Greggi S, Colombo A, Neoadjuvant chemotherapy and radical surgery versus exclusive radiotherapy in locally advanced squamous cell cervical cancer: results from the Italian multicenter randomized study. J Clin Oncol 2002;20:179-88
   PubMed Web of Science ®Google Scholar
• Chen H, Liang C, Zhang L, Clinical efficacy of modified preoperative neoadjuvant chemotherapy in the treatment of locally advanced (stage IB2 to IIB) cervical cancer: randomized study. Gynecol Oncol 2008;110:308-15
   PubMed Web of Science ®Google Scholar
• Park DC, Suh MJ, Yeo SG. Neoadjuvant paclitaxel and cisplatin in uterine cervical cancer: long-term results. Int J Gynecol Cancer 2009;19:943-7
   PubMed Web of Science ®Google Scholar
• Kumar JV, Doval DC, Rao R, Rawal S. A retrospective study of patients with locally advanced cancer of the cervix treated with neoadjuvant chemotherapy followed by radical surgery. Int J Gynecol Cancer 2009;19:417-22
   PubMedGoogle Scholar
• Eddy GL, Bundy BN, Creasman WT, Treatment of (‘bulky’) stage IB cervical cancer with or without neoadjuvant vincristine and cisplatin prior to radical hysterectomy and pelvic/para-aortic lymphadenectomy: a phase III trial of the gynecologic oncology group. Gynecol Oncol 2007;106:362-9
   PubMedGoogle Scholar
• Behtash N, Nazari Z, Ayatollahi H, Neoadjuvant chemotherapy and radical surgery compared to radical surgery alone in bulky stage IB – IIA cervical cancer. Eur J Surg Oncol 2006;32:1226-30
   PubMedGoogle Scholar
• Benedetti-Panici P, Greggi S, Scambia G, Long-term survival following neoadjuvant chemotherapy and radical surgery in locally advanced cervical cancer. Eur J Cancer 1998;34:341-6
   PubMedGoogle Scholar
• Buda A, Fossati R, Colombo N, Randomized trial of neoadjuvant chemotherapy comparing paclitaxel, ifosfamide, and cisplatin with ifosfamide and cisplatin followed by radical surgery in patients with locally advanced squamous cell cervical carcinoma: the SNAP01 (Studio Neo-Adjuvante Portio) Italian Collaborative Study. J Clin Oncol 2005;23:4137-45
   PubMed Web of Science ®Google Scholar
• Leone B, Vallejo C, Perez J, Ifosfamide and cisplatin as neoadjuvant chemotherapy for advanced cervical carcinoma. Am J Clin Oncol 1996;19:132-5
   PubMed Web of Science ®Google Scholar
• Zanetta G, Lissoni A, Pellegrino A, Neoadjuvant chemotherapy with cisplatin, ifosfamide and paclitaxel for locally advanced squamous-cell cervical cancer. Ann Oncol 1998;9:977-80
   PubMed Web of Science ®Google Scholar
• Aoki Y, Tomita M, Sato T, Neoadjuvant chemotherapy for patients younger than 50 years with high-risk squamous cell carcinoma of the cervix. Gynecol Oncol 2001;83:263-7
   PubMedGoogle Scholar
• Duenas-Gonzalez A, Lopez-Graniel C, Gonzalez-Enciso A, A Phase II study of multimodality treatment for locally advanced cervical cancer: neoadjuvant carboplatin and paclitaxel followed by radical hysterectomy and adjuvant cisplatin chemoradiation. Ann Oncol 2003;14:1278-84
   PubMed Web of Science ®Google Scholar
• Park DC, Kim JH, Lew YO, Phase II trial of neoadjuvant paclitaxel and cisplatin in uterine cervical cancer. Gynecol Oncol 2004;92:59-63
   PubMed Web of Science ®Google Scholar
• Chang TC, Lai CH, Hong JH, Randomized trial of neoadjuvant cisplatin, vincristine, bleomycin, and radical hysterectomy versus radiation therapy for bulky stage IB and IIA cervical cancer. J Clin Oncol 2000;18:1740-7
   PubMed Web of Science ®Google Scholar
• Vallejo CT, Machiavelli MR, Perez JE, Docetaxel as neoadjuvant chemotherapy in patients with advanced cervical carcinoma. Am J Clin Oncol 2003;26:477-82
   PubMed Web of Science ®Google Scholar
• World Health Organization. WHO handbook for reporting results of cancer treatment (offset publication no. 48). World Health Organization, Geneva; 1979. p. 16-21
   Google Scholar
• National Cancer Institute. Common Terminology Criteria for Adverse Events (CTCAE version 3.0), published 9 August 2006. Available from: http://ctep.cancer.gov/protocolDevelopment/electronic_applications/ctc.htm [Last accessed 17 April 2010]
   Google Scholar
• Chang HC, Lai CH, Chou PC, Neoadjuvant chemotherapy with cisplatin, vincristine, and bleomycin and radical surgery in early-stage bulky cervical carcinoma. Cancer Chemother Pharmacol 1992;30:281-5
   PubMed Web of Science ®Google Scholar
• Cho YH, Kim DY, Kim JH, Comparative study of neoadjuvant chemotherapy before radical hysterectomy and radical surgery alone in stage IB2 – IIA bulky cervical cancer. J Gynecol Oncol 2009;20:22-7
   PubMedGoogle Scholar
• Kokawa K, Nishimura R, Fujii T, Umesaki N. Neoadjuvant chemotherapy with irinotecan and mitomycin-C for locally advanced squamous cell carcinoma of the uterine cervix. Anticancer Res 2007;27:2721-7
   PubMedGoogle Scholar
• Bae JH, Lee SJ, Lee A, Neoadjuvant cisplatin and etoposide followed by radical hysterectomy for stage 1B – 2B cervical cancer. Gynecol Oncol 2008;111:444-8
   PubMedGoogle Scholar
• Duenas-Gonzalez A, Lopez-Graniel C, Gonzalez-Enciso A, Concomitant chemoradiation versus neoadjuvant chemotherapy in locally advanced cervical carcinoma: results from two consecutive phase II studies. Ann Oncol 2002;13:1212-19
   PubMedGoogle Scholar
• Nagao S, Fujiwara K, Oda T, Combination chemotherapy of docetaxel and carboplatin in advanced or recurrent cervix cancer. A pilot study. Gynecol Oncol 2005;96:805-9
   PubMed Web of Science ®Google Scholar
• Benedetti-Panici P, Scambia G, Baiocchi G, Neoadjuvant chemotherapy and radical surgery in locally advanced cervical cancer. prognostic factors for response and survival. Cancer 1991;67:372-9
   PubMedGoogle Scholar
• Choi YS, Sin JI, Kim JH, Survival benefits of neoadjuvant chemotherapy followed by radical surgery versus radiotherapy in locally advanced chemoresistant cervical cancer. J Korean Med Sci 2006;21:683-9
   PubMedGoogle Scholar